Cargando…

Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2

Cisplatin is a common used chemotherapeutic drug for the treatment of laryngeal cancer. However, drug-resistance is a major obstacle in platinum-based chemotherapy for laryngeal cancer. Recent studies have demonstrated that dysregulation of microRNAs (miRNAs) is responsible for chemoresistance in mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Linli, Zhang, Jiarui, Ren, Xiuxia, Liu, Xinyu, Gao, Wei, Zhang, Chen, Sun, Yanan, Liu, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668017/ https://www.ncbi.nlm.nih.gov/pubmed/29108284 http://dx.doi.org/10.18632/oncotarget.20784

Ejemplares similares

Effect of DACH1 on proliferation and invasion of laryngeal squamous cell carcinoma
por: Zhang, Jiarui, et al.
Publicado: (2018)

Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC
por: Li, MingHua, et al.
Publicado: (2013)

Circular RNA 103862 Promotes Proliferation and Invasion of Laryngeal Squamous Cell Carcinoma Cells Through the miR-493-5p/GOLM1 Axis
por: Wang, Xin, et al.
Publicado: (2020)

Overexpression of miR-1283 Inhibits Cell Proliferation and Invasion of Glioma Cells by Targeting ATF4
por: Chen, Hao, et al.
Publicado: (2019)

Identification of laryngeal cancer prognostic biomarkers using an inflammatory gene-related, competitive endogenous RNA network
por: He, Qun, et al.
Publicado: (2016)

Coordinated Regulation of ATF2 by miR-26b in γ-Irradiated Lung Cancer Cells
por: Arora, Himanshu, et al.
Publicado: (2011)

Magnesium Isoglycyrrhizinate Induces an Inhibitory Effect on Progression and Epithelial–Mesenchymal Transition of Laryngeal Cancer via the NF-κB/Twist Signaling
por: Zhang, Jiarui, et al.
Publicado: (2020)

Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway
por: Wang, Peng, et al.
Publicado: (2016)

Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis
por: Wu, Tianyi, et al.
Publicado: (2016)

Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells
por: Liu, Jiajia, et al.
Publicado: (2016)

lncRNA IGKJ2 ‐MALLP2 suppresses LSCC proliferation, migration, invasion, and angiogenesis by sponging miR‐1911‐3p/p21
por: Cao, Jing, et al.
Publicado: (2020)

Regulation of laryngeal squamous cell cancer progression by the lncRNA RP11‐159K7.2/miR‐206/DNMT3A axis
por: Wang, Xin, et al.
Publicado: (2020)

MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer
por: Li, Jiarui, et al.
Publicado: (2012)

lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway
por: Liu, Yan, et al.
Publicado: (2020)

Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98
por: Alajez, N M, et al.
Publicado: (2010)

miR-204 suppresses the development and progression of human glioblastoma by targeting ATF2
por: Song, Shiwei, et al.
Publicado: (2016)

Down‐regulation of miR‐26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1
por: Shi, Lei, et al.
Publicado: (2016)

MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
por: Bissey, Pierre-Antoine, et al.
Publicado: (2020)

ATF2-Induced Overexpression of lncRNA LINC00882, as a Novel Therapeutic Target, Accelerates Hepatocellular Carcinoma Progression via Sponging miR-214-3p to Upregulate CENPM
por: Ren, Hua, et al.
Publicado: (2021)

Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin
por: Zang, Shuzhi, et al.
Publicado: (2019)

Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival
por: Lee, D H, et al.
Publicado: (2013)

miR106a Promotes the Growth of Transplanted Breast Cancer and Decreases the Sensitivity of Transplanted Tumors to Cisplatin
por: You, Faping, et al.
Publicado: (2020)

miR-339-5p Inhibits Autophagy to Reduce the Resistance of Laryngeal Carcinoma on Cisplatin via Targeting TAK1
por: Li, Guang, et al.
Publicado: (2021)

Decreased miR-26a Expression Correlates with the Progression of Podocyte Injury in Autoimmune Glomerulonephritis
por: Ichii, Osamu, et al.
Publicado: (2014)

Overexpression of miR -155 Promotes Proliferation and Invasion of Human Laryngeal Squamous Cell Carcinoma via Targeting SOCS1 and STAT3
por: Zhao, Xu-dong, et al.
Publicado: (2013)

An ATF(24) peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment
por: Zhai, Bingtao, et al.
Publicado: (2020)

CircRNA_102272 Promotes Cisplatin-Resistance in Hepatocellular Carcinoma by Decreasing MiR-326 Targeting of RUNX2
por: Guan, Yonghai, et al.
Publicado: (2020)

Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun
por: Huang, Gang, et al.
Publicado: (2017)

MiR-26a/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1
por: Wei, Zhenxing, et al.
Publicado: (2020)

Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1
por: Cheng, Ruirui, et al.
Publicado: (2022)

Decreased Expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4(+) T Cells and Peripheral Blood from Tuberculosis Patients
por: Kleinsteuber, Katja, et al.
Publicado: (2013)

miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma
por: Wu, Ying, et al.
Publicado: (2016)

ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer
por: Song, Qiong, et al.
Publicado: (2018)

miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1
por: Wang, Yanan, et al.
Publicado: (2018)

Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer
por: Li, Yang, et al.
Publicado: (2017)

MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells
por: Zhao, Yu, et al.
Publicado: (2014)

TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2
por: He, Guoqing, et al.
Publicado: (2021)

MiR‐200c‐3p and miR‐485‐5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non–small cell lung cancer cells through targeting RRM2
por: Liu, Ying, et al.
Publicado: (2022)

Sevoflurane promotes the apoptosis of laryngeal squamous cell carcinoma in-vitro and inhibits its malignant progression via miR-26a/FOXO1 axis
por: Liu, Dan, et al.
Publicado: (2021)

Overexpression of xeroderma pigmentosum group C decreases the chemotherapeutic sensitivity of colorectal carcinoma cells to cisplatin
por: Zhang, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fas88i7k9mv8ob5ba196o1g3th